以亚急性肝衰竭为首发表现的IgG4相关性自身免疫性肝炎1例报告
DOI: 10.3969/j.issn.1001-5256.2022.01.028
利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:刘慧敏负责文章设计,病例资料分析,撰写论文; 蒋黎参与收集数据,修改论文; 毛青负责拟定写作思路,指导撰写文章并最后定稿。
IgG4-related autoimmune hepatitis with subacute liver failure as the initial manifestation: A case report
-
-
Key words:
- Hepatitis, Autoimmune /
- Liver Failure, Acute /
- Immunoglobulin G
-
表 1 血生化指标随访情况
时间 ALT(U/L) AST(U/L) GGT(U/L) ALP(U/L) Alb(g/L) TBil(μmol/L) DBil(μmol/L) PT-INR PLT(×109/L) 2021/2/8 717 1220 348 553 22.10 305.18 222.97 1.19 94 2021/2/13 228 251 247 370 25.26 301.68 212.30 1.63 97 2021/2/24 165 259 261 390 33.8 436.35 326.05 1.70 98 2021/3/4 107 109 237 229 29.43 233.89 179.00 1.41 41 2021/3/11 72 89 233 192 31.01 152.01 114.50 1.32 65 2021/3/15 71 84 254 215 30.50 124.40 82.75 1.49 70 2021/4/3 75 386 385 350 22.00 158.30 115.80 1.34 73 2021/4/8 101 391 302 335 29.50 169.00 108.60 1.50 65 2021/4/16 102 120 235 240 31.20 138.40 88.90 1.48 79 2021/4/22 79 79 192 198 25.30 134.70 98.50 1.22 73 2021/4/27 59 58 160 146 29.70 87.70 65.80 1.46 65 -
[1] MINAGA K, WATANABE T, CHUNG H, et al. Autoimmune hepatitis and IgG4-related disease[J]. World J Gastroenterol, 2019, 25(19): 2308-2314. DOI: 10.3748/wjg.v25.i19.2308. [2] UMEMURA T, ZEN Y, HAMANO H, et al. IgG4 associated autoimmune hepatitis: A differential diagnosis for classical autoimmune hepatitis[J]. Gut, 2007, 56(10): 1471-1472. DOI: 10.1136/gut.2007.122283. [3] UMEMURA T, ZEN Y, HAMANO H, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis[J]. J Gastroenterol, 2011, 46(Suppl 1): 48-55. DOI: 10.1007/s00535-010-0323-4. [4] Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol, 2016, 32(1): 9-22. DOI: 10.3969/j.issn.1001-5256.2016.01.002.中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 自身免疫性肝炎诊断和治疗共识(2015)[J]. 临床肝胆病杂志, 2016, 32(1): 9-22. DOI: 10.3969/j.issn.1001-5256.2016.01.002. [5] SHI XD, WEI Q, YU M, et al. Research advances in diagnosis and treatment of IgG4-associated autoimmune hepatitis[J]. J Clin Hepatol, 2016, 32(9): 1819-1821. DOI: 10.3969/j.issn.1001-5256.2016.09.042.石晓东, 魏琪, 余敏, 等. IgG4相关自身免疫性肝炎诊治的研究进展[J]. 临床肝胆病杂志, 2016, 32(9): 1819-1821. DOI: 10.3969/j.issn.1001-5256.2016.09.042. [6] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.中华医学会感染病学分会肝衰竭与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. [7] MACK CL, ADAMS D, ASSIS DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases[J]. Hepatology, 2020, 72(2): 671-722. DOI: 10.1002/hep.31065. [8] FISCHER HP, GOLTZ D. Autoimmune liver diseases[J]. Pathologe, 2020, 41(5): 444-456. DOI: 10.1007/s00292-020-00807-7. [9] STONE JH, ZEN Y, DESHPANDE V. IgG4-related disease[J]. N Engl J Med, 2012, 366(6): 539-551. DOI: 10.1056/NEJMra1104650. [10] KAMISAWA T, FUNATA N, HAYASHI Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease[J]. J Gastroenterol, 2003, 38(10): 982-984. DOI: 10.1007/s00535-003-1175-y. [11] HAMANO H, KAWA S, HORIUCHI A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis[J]. N Engl J Med, 2001, 344(10): 732-738. DOI: 10.1056/NEJM200103083441005. [12] BRITO-ZERÓN P, RAMOS-CASALS M, BOSCH X, et al. The clinical spectrum of IgG4-related disease[J]. Autoimmun Rev, 2014, 13(12): 1203-1210. DOI: 10.1016/j.autrev.2014.08.013. [13] JOSHI D, WEBSTER GJ. Biliary and hepatic involvement in IgG4-related disease[J]. Aliment Pharmacol Ther, 2014, 40(11-12): 1251-1261. DOI: 10.1111/apt.12988. [14] AITHAL GP, BRESLIN NP, GUMUSTOP B. High serum IgG4 concentrations in patients with sclerosing pancreatitis[J]. N Engl J Med, 2001, 345(2): 147-148. DOI: 10.1056/NEJM200107123450215. [15] ZEN Y, HARADA K, SASAKI M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: Do they belong to a spectrum of sclerosing pancreatitis?[J]. Am J Surg Pathol, 2004, 28(9): 1193-1203. DOI: 10.1097/01.pas.0000136449.37936.6c. [16] NAKAZAWA T, NAITOH I, HAYASHI K, et al. Diagnosis of IgG4-related sclerosing cholangitis[J]. World J Gastroenterol, 2013, 19(43): 7661-7670. DOI: 10.3748/wjg.v19.i43.7661. [17] CHUNG H, WATANABE T, KUDO M, et al. Identification and characterization of IgG4-associated autoimmune hepatitis[J]. Liver Int, 2010, 30(2): 222-231. DOI: 10.1111/j.1478-3231.2009.02092.x. [18] AMARAPURKAR AD, AMARAPURKAR DN. Immunoglobulin IgG4 and autoimmune hepatitis[J]. Trop Gastroenterol, 2015, 36(2): 112-117. DOI: 10.7869/tg.263. [19] WATANABE T, YAMASHITA K, ARAI Y, et al. Chronic fibro-inflammatory responses in autoimmune pancreatitis depend on IFN-α and IL-33 produced by plasmacytoid dendritic cells[J]. J Immunol, 2017, 198(10): 3886-3896. DOI: 10.4049/jimmunol.1700060. [20] ARAI Y, YAMASHITA K, KURIYAMA K, et al. Plasmacytoid dendritic cell activation and IFN-α production are prominent features of murine autoimmune pancreatitis and human IgG4-related autoimmune pancreatitis[J]. J Immunol, 2015, 195(7): 3033-3044. DOI: 10.4049/jimmunol.1500971. [21] CANIVET CM, ANTY R, PATOURAUX S, et al. Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries[J]. Dig Liver Dis, 2016, 48(3): 302-308. DOI: 10.1016/j.dld.2015.10.005.